Metropolis Healthcare · NSE: METROPOLIS · BSE: 542650
Q3 FY25 results · Oct–Dec 2024
Metropolis Healthcare reported revenue from operations of ₹322.77 crore (up 10.9% from Q3 FY24) and net profit of ₹31.47 crore (up 15.3% from Q3 FY24) for Q3 FY25 (Oct–Dec 2024), on a consolidated basis.
| Item | Q3 FY25 | Q3 FY24 | YoY | Q2 FY25 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 322.77 | 291.12 | +10.9% | 349.79 | −7.7% |
| Other income | 2.56 | 2.31 | +10.8% | 3.13 | −18.3% |
| Total income | 325.32 | 293.42 | +10.9% | 352.92 | −7.8% |
| Profit before tax | 42.34 | 36.85 | +14.9% | 61.40 | −31.0% |
| Net profit for the period | 31.47 | 27.29 | +15.3% | 46.70 | −32.6% |
| Attributable to shareholders of the company | 31.36 | 27.16 | +15.5% | 46.52 | −32.6% |
| EPS, basic (₹) | 6.11 | 5.30 | +15.3% | 9.08 | −32.6% |
| Net margin (%) | 9.8 | 9.4 | 13.4 |
| Item | Q3 FY25 | Q3 FY24 | YoY | Q2 FY25 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 296.88 | 269.41 | +10.2% | 321.57 | −7.7% |
| Other income | 3.03 | 5.19 | −41.6% | 3.59 | −15.6% |
| Total income | 299.91 | 274.60 | +9.2% | 325.16 | −7.8% |
| Profit before tax | 36.80 | 34.63 | +6.3% | 54.87 | −32.9% |
| Net profit for the period | 27.40 | 26.70 | +2.6% | 42.26 | −35.2% |
| EPS, basic (₹) | 5.35 | 5.21 | +2.7% | 8.24 | −35.1% |
| Net margin (%) | 9.2 | 9.9 | 13.1 |
Consolidated
- Filed with BSE
- 04 Feb 2025, 19:56 IST
- Board meeting
- 04 Feb 2025
- Period
- 01 Oct 2024 to 31 Dec 2024
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 04 Feb 2025, 19:56 IST
- Board meeting
- 04 Feb 2025
- Period
- 01 Oct 2024 to 31 Dec 2024
- Review status
- Unaudited
- Source
- XBRL filing on BSE